GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2026
GlobeImmune Revenue
GlobeImmune had revenue of $942.75K in the quarter ending March 31, 2016, a decrease of -20.63%. This brings the company's revenue in the last twelve months to $6.21M, up 8.31% year-over-year. In the year 2015, GlobeImmune had annual revenue of $6.46M with 8.24% growth.
Revenue (ttm)
6.21M
Revenue Growth
+8.31%
P/S Ratio
0.00
Revenue / Employee
2.07M
Employees
3
Market Cap
575.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2015 | 6.46M | 491.35K | 8.24% |
| Dec 31, 2014 | 5.97M | -16.55M | -73.50% |
| Dec 31, 2013 | 22.52M | 7.88M | 53.80% |
| Dec 31, 2012 | 14.64M | 9.53M | 186.65% |
| Dec 31, 2011 | 5.11M | 1.04M | 25.57% |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nabriva Therapeutics | 29.56M |
| Predictive Technology Group | 19.17M |
| Alzex Neuropharma | 4.73M |
| U.S. Stem Cell | 82.05K |
| RegeneRx Biopharmaceuticals | 76.76K |